The BMPR1A Gene Polyposis Syndrome Hereditary Mixed Type 2 Genetic Test is a sophisticated diagnostic tool offered by DNA Labs UAE, designed to identify mutations in the BMPR1A gene. These mutations are linked to Hereditary Mixed Polyposis Syndrome Type 2 (HMPS2), a rare condition that predisposes individuals to developing multiple polyps in the gastrointestinal tract. These polyps have the potential to become cancerous if left undetected and untreated. The condition follows an autosomal dominant inheritance pattern, meaning a mutation in just one of the two copies of the gene can lead to the syndrome.
The test, priced at 4400 AED, involves collecting a DNA sample from the patient, usually through a blood draw or a cheek swab. The sample is then analyzed in the laboratory using advanced genetic sequencing technologies to detect any abnormalities in the BMPR1A gene. The result from this test can provide crucial information for individuals with a family history of polyposis syndromes or early-onset colorectal cancer, enabling them to make informed decisions about their health management.
Early detection through genetic testing like the BMPR1A Gene Polyposis Syndrome Hereditary Mixed Type 2 Genetic Test allows for timely surveillance and intervention, significantly reducing the risk of developing colorectal cancer associated with the syndrome. Furthermore, it can guide genetic counseling and testing for family members who may also be at risk.
The STAG1 Gene Prostate Cancer Genetic Test is a sophisticated diagnostic tool designed to identify genetic mutations within the STAG1 gene, which have been linked to an increased risk of developing prostate cancer. This genetic test serves as a pivotal measure for early detection and risk assessment, enabling healthcare providers to tailor personalized prevention strategies and treatment plans for individuals at higher risk. Conducted at DNA Labs UAE, a leading facility in genetic testing, the test ensures accuracy and confidentiality. The cost of the STAG1 Gene Prostate Cancer Genetic Test is 4400 AED, reflecting the intricate technology and expertise involved in detecting these specific genetic variations. By opting for this test, individuals can gain valuable insights into their genetic predisposition towards prostate cancer, facilitating early interventions and potentially improving outcomes.
The MMR (Mismatch Repair) genes methylation analysis genetic test is a sophisticated diagnostic tool offered by DNA Labs UAE, designed to detect abnormalities in the MMR genes that could indicate a predisposition to certain types of cancer, most notably Lynch syndrome. Lynch syndrome is a hereditary condition that significantly increases an individual's risk of developing colorectal cancer, endometrial cancer, and several other forms of cancer at a younger age than typically observed in the general population.
MMR genes are crucial for the repair of mismatch errors that can occur during DNA replication. When these genes are methylated, or chemically modified, their function can be impaired, leading to an accumulation of genetic mutations and an increased risk of cancer. Methylation analysis of MMR genes involves examining the DNA to identify any abnormal methylation patterns that may suggest a dysfunction in these critical genes.
Conducted at DNA Labs UAE, a leading facility in genetic diagnostics, the test provides valuable insights for individuals with a family history of cancers associated with Lynch syndrome or those who have personal health concerns based on their medical history. The process involves collecting a DNA sample, typically through a blood draw or a cheek swab, which is then analyzed using advanced genetic testing technologies.
The cost of the MMR genes methylation analysis genetic test at DNA Labs UAE is 4400 AED. This investment covers the comprehensive analysis required to accurately assess the methylation status of the MMR genes and provide a detailed report that can guide individuals and their healthcare providers in making informed decisions about cancer surveillance and prevention strategies. Given the potential health implications, this test represents a crucial step for those at risk, offering a proactive approach to managing and mitigating cancer risk associated with genetic factors.
The "MPL Gene MPL Selective Sequencing of Exon 10 Genetic Test" is a specialized diagnostic tool available at DNA Labs UAE, designed to analyze the MPL gene, specifically focusing on exon 10. This targeted approach helps in identifying mutations that may be implicated in various blood disorders, including myeloproliferative neoplasms (MPNs). MPNs are a group of diseases where bone marrow cells that produce blood cells develop and function abnormally. Mutations in the MPL gene, especially in exon 10, can lead to abnormal thrombopoietin receptor activation, affecting blood cell production and function.
This test is particularly valuable for patients who exhibit symptoms suggestive of MPNs or for those with a family history of such conditions, as it allows for a precise genetic diagnosis. By pinpointing specific genetic alterations, healthcare providers can tailor treatment strategies more effectively, potentially improving patient outcomes.
The cost of the MPL Gene MPL Selective Sequencing of Exon 10 Genetic Test at DNA Labs UAE is 4400 AED. Given the complexity of the analysis and the specialized technology used, the price reflects the depth of insight the test provides into the patient's genetic makeup, aiding in the accurate diagnosis and management of blood disorders.
The MLH1 Gene Muir-Torre Syndrome Genetic Test is a specialized diagnostic procedure available at DNA Labs UAE, designed to identify mutations in the MLH1 gene, which are strongly associated with Muir-Torre Syndrome (MTS). Muir-Torre Syndrome is a rare, autosomal dominant genetic condition characterized by the combination of sebaceous gland tumors and internal malignancies, most commonly affecting the gastrointestinal tract and genitourinary system. The MLH1 gene plays a crucial role in DNA mismatch repair; mutations in this gene disrupt the repair process, leading to increased risk of cancer.
This test is particularly recommended for individuals with a personal or family history of cancers associated with MTS, or those displaying clinical features of the syndrome. Early detection through genetic testing can significantly aid in the management and surveillance strategies for affected individuals and their families, potentially reducing the risk of developing related cancers.
The test cost at DNA Labs UAE is set at 4400 AED. Conducted in a state-of-the-art facility, DNA Labs UAE ensures accuracy, confidentiality, and comprehensive support throughout the testing process. The results from this test can provide invaluable information for both the individual tested and their healthcare provider, facilitating informed decisions regarding future medical care and surveillance measures.
The MSH2 Gene Muir-Torre Syndrome Genetic Test is a specialized diagnostic tool offered by DNA Labs UAE, designed to identify mutations in the MSH2 gene, which are linked to Muir-Torre Syndrome (MTS). Muir-Torre Syndrome is a rare, autosomal dominant genetic disorder characterized by the occurrence of both skin tumors and internal malignancies, primarily in the gastrointestinal tract. The MSH2 gene plays a crucial role in DNA repair, and mutations in this gene can lead to the development of cancer.
This test is particularly important for individuals with a family history of MTS or related cancers, as it can provide crucial information for disease management and prevention strategies. The process involves collecting a DNA sample, typically through a blood draw or cheek swab, which is then analyzed in the laboratory for the presence of mutations in the MSH2 gene.
The cost of the MSH2 Gene Muir-Torre Syndrome Genetic Test at DNA Labs UAE is 4400 AED. This investment includes the testing procedure, analysis, and comprehensive reporting. The results from this test can help healthcare providers develop a personalized approach to monitoring and managing the patient's health, potentially including increased surveillance for cancers associated with MTS and guidance for family members who may also be at risk.
Given the implications of the results for both the individual tested and their family members, genetic counseling is often recommended alongside testing to ensure that individuals fully understand the potential outcomes and implications of the test.
The CDKN2B gene plays a crucial role in regulating cell division by controlling the cell cycle, thus acting as a tumor suppressor. Mutations or alterations in this gene can lead to various forms of cancer, including multiple endocrine neoplasia type 1 (MEN1). MEN1 is a rare hereditary condition characterized by the development of tumors in endocrine glands, such as the parathyroid, pituitary, and pancreas, which can be benign or malignant.
The CDKN2B-related genetic test is a specialized diagnostic tool designed to identify mutations in the CDKN2B gene that are associated with an increased risk of developing MEN1. This test is particularly important for individuals with a family history of MEN1 or related symptoms, as it can help in early diagnosis and management of the condition.
DNA Labs UAE offers the CDKN2B gene multiple endocrine neoplasia type 1 related genetic test. The test is conducted using advanced genetic sequencing techniques to ensure accuracy and reliability. The cost of the test is 4400 AED, which includes the analysis and interpretation of results by certified genetic counselors. By identifying individuals at risk, this test enables proactive monitoring and intervention, potentially reducing the impact of MEN1 on affected individuals and their families.
The RET Gene Multiple Endocrine Neoplasia Type 2A (MEN2A) Genetic Test is a specialized diagnostic procedure offered by DNA Labs UAE, designed to identify mutations in the RET gene that are associated with MEN2A. MEN2A is a hereditary condition characterized by the development of tumors in multiple endocrine glands, including the thyroid gland, parathyroid glands, and adrenal glands. These tumors can be benign or malignant and can significantly impact an individual's health.
The test involves analyzing the patient's DNA to detect specific mutations in the RET gene that have been linked to the development of MEN2A. Identifying these mutations can be crucial for early diagnosis, which is essential for effective management and treatment of the condition. It can also provide valuable information for family members who may be at risk.
DNA Labs UAE offers this genetic test at a cost of 4400 AED. The testing process is conducted with high standards of accuracy and confidentiality, ensuring that patients receive reliable and comprehensive genetic information. This test is particularly recommended for individuals with a family history of MEN2A or related symptoms, as it can guide critical decisions regarding surveillance and preventive measures.
The RET Gene Multiple Endocrine Neoplasia Type 2B (MEN 2B) Genetic Test is a specialized diagnostic procedure aimed at detecting mutations in the RET gene, which are associated with the development of MEN 2B. This condition is a rare, hereditary cancer syndrome that predominantly affects the endocrine glands, leading to the growth of multiple neoplasms within these glands. MEN 2B is characterized by medullary thyroid carcinoma, pheochromocytomas, mucosal neuromas, and a Marfanoid habitus.
DNA Labs UAE offers this comprehensive genetic test, which is crucial for individuals with a family history of MEN 2B or those presenting symptoms related to this condition. Early detection through genetic testing can significantly influence the management and treatment strategies, potentially improving the prognosis and quality of life for affected individuals.
The cost of the RET Gene Multiple Endocrine Neoplasia Type 2B Genetic Test at DNA Labs UAE is 4400 AED. This investment covers the analysis of the RET gene for mutations that confer a high risk of MEN 2B. Given the complexity of the condition and the implications of the test results, genetic counseling is often recommended alongside testing to provide individuals and families with comprehensive support and guidance.
The CDKN1B Gene Multiple Endocrine Neoplasia Type 4 Genetic Test is a specialized diagnostic procedure available at DNA Labs UAE, designed to detect mutations in the CDKN1B gene, which are linked to Multiple Endocrine Neoplasia Type 4 (MEN4). MEN4 is a rare hereditary condition characterized by the development of tumors or overgrowth in multiple endocrine glands, including the parathyroid, adrenal, and pituitary glands. This condition can lead to various health issues, including hormonal imbalances and increased risk of certain cancers.
The test is crucial for individuals with a family history of MEN4 or those presenting symptoms associated with the condition, as early detection can significantly influence management and treatment strategies. Conducted through a simple blood sample, the genetic analysis focuses on identifying mutations in the CDKN1B gene, which plays a pivotal role in cell cycle regulation. Identifying mutations in this gene can confirm a diagnosis of MEN4, enabling proactive health management and surveillance for affected individuals and their families.
The cost of the CDKN1B Gene Multiple Endocrine Neoplasia Type 4 Genetic Test at DNA Labs UAE is set at 4400 AED. This investment covers the comprehensive analysis and expert interpretation of results, ensuring patients and healthcare providers have the necessary information for informed decision-making regarding treatment and preventive measures.
